PREMAL LULLA to Prognosis
This is a "connection" page, showing publications PREMAL LULLA has written about Prognosis.
Connection Strength
0.167
-
The use of chimeric antigen receptor T cells in patients with non-Hodgkin lymphoma. Clin Adv Hematol Oncol. 2018 May; 16(5):375-386.
Score: 0.077
-
Sustained complete remission of metastatic hepatocellular carcinoma with single agent sorafenib. J Gastrointest Cancer. 2013 Mar; 44(1):98-101.
Score: 0.054
-
T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425.
Score: 0.023
-
Retrospective review of extra-pulmonary small cell carcinoma and prognostic factors. Int J Clin Oncol. 2014 Oct; 19(5):822-8.
Score: 0.014